Search hospitals > New York > New York
Bellevue Hosp / New York Univ Med Ctr
Claim this profileNew York, New York 10016
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Infections
Conducts research for AIDS
Conducts research for Contagious Diseases
Conducts research for Opioid Use Disorder
196 reported clinical trials
10 medical researchers
Summary
Bellevue Hosp / New York Univ Med Ctr is a medical facility located in New York, New York. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, AIDS, Contagious Diseases, Opioid Use Disorder and other specialties. Bellevue Hosp / New York Univ Med Ctr is involved with conducting 196 clinical trials across 170 conditions. There are 10 research doctors associated with this hospital, such as Nina Beri, MD, Maryann Kwa, MD, Violeta Popov, MD, and Mathew Kladney, MD.Top PIs
Nina Beri, MDLaura and Isaac Perlmutter Cancer Center at NYU Langone6 years of reported clinical research
Studies Colorectal Cancer
Studies Tumors
10 reported clinical trials
28 drugs studied
Maryann Kwa, MDLaura and Isaac Perlmutter Cancer Center at NYU Langone6 years of reported clinical research
Studies Breast Cancer
Studies Cancer
4 reported clinical trials
9 drugs studied
Violeta Popov, MDManhattan VA Medical Center3 years of reported clinical research
Studies Polyps
Studies Colonic Polyps
2 reported clinical trials
3 drugs studied
Mathew Kladney, MDBellevue Hospital Center3 years of reported clinical research
Studies Substance Use Disorders
Studies Opioid Use Disorder
1 reported clinical trial
6 drugs studied
Clinical Trials running at Bellevue Hosp / New York Univ Med Ctr
Opioid Use Disorder
Gallbladder Cancer
Diabetes
Type 1 Diabetes
Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Breast Cancer
Substance Use Disorders
Bile Duct Cancer
Klatskin Tumor
Buprenorphine
for Opioid Use Disorder
This study will (1) recruit, train and provide resources to approximately 30 Emergency Department (ED) sites throughout the U.S. using implementation facilitation strategies to provide ED-initiated buprenorphine (BUP) for patients presenting with opioid use disorder (OUD) who are not receiving medications for opioid use disorder (MOUD). Once implementation is adequately achieved, the sites will (2) conduct a randomized controlled trial (RCT) to compare the effectiveness of sublingual buprenorphine (SL-BUP) versus extended-release buprenorphine (XR-BUP) on ED patients' engagement in formal addiction treatment 7-days after their ED visit. In addition, in an ancillary component of the study, the investigators will (3) assess the use of XR-BUP in ED patients with Clinical Opioid Withdrawal Scale (COWS) scores \< 8 in a case series to potentially expand the eligibility of patients in the larger RCT to those presenting with little to no opioid withdrawal symptoms. Finally, the investigators will (4) develop and validate ED electronic health record (EHR) opioid-related phenotypes, both of which will inform the main RCT.
Recruiting3 awards Phase 218 criteria
Pharmacotherapy Strategies
for Opioid Use Disorder
This is a two phase study investigating combinations of pharmacological and behavioral interventions to optimize the treatment of Opioid Use Disorder (OUD). The Retention Phase will assess strategies for improving retention on buprenorphine (BUP) and extended-release injectable naltrexone (XR-NTX). The Discontinuation Phase will assess which approaches are most likely to lead to long-term success (absence of relapse), and what characteristics of participants distinguish those who can safely discontinue Medications for Opioid Use Disorder (MOUD) from those who remain at risk of relapse and should not discontinue.
Recruiting1 award Phase 29 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Bellevue Hosp / New York Univ Med Ctr?
Bellevue Hosp / New York Univ Med Ctr is a medical facility located in New York, New York. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, AIDS, Contagious Diseases, Opioid Use Disorder and other specialties. Bellevue Hosp / New York Univ Med Ctr is involved with conducting 196 clinical trials across 170 conditions. There are 10 research doctors associated with this hospital, such as Nina Beri, MD, Maryann Kwa, MD, Violeta Popov, MD, and Mathew Kladney, MD.